ORCL enters its September 4 earnings print nursing a 5.2% single-day loss to $141.32 — the headline now is not how much hedging has built up ahead of the report, but how badly the stock has sold off with results still a day away.
The options market was already the loudest signal through August, and it remains so. The put/call ratio closed Tuesday at 0.89, more than 1.7 standard deviations above its 20-day average of 0.82 — the highest defensive reading of the past year. That gauge has climbed steadily across the final two weeks of August, and the previous two notes flagged the same direction of travel. What has changed is the context: the stock that was trading near $149 on August 31 is now at $141, meaning the pre-print hedging has been accompanied by real price damage. The 52-week PCR high of 1.06 still has room to run. The lending market remains the clean counterpoint. Availability is effectively unlimited — the pool of lendable shares vastly exceeds any short demand — and cost to borrow, at 0.32%, has risen 43% over the week but remains trivially low in absolute terms. Short interest is just 1.7% of float, down 3.5% on the week. There is no short-side conviction here. The caution is concentrated entirely in options.
Analysts are moving in one direction, and that direction is lower. Jefferies trimmed its target from $320 to $290 on September 2, maintaining Buy. TD Cowen cut from $300 to $240 on September 1, also keeping Buy. Both moves arrived in the 48 hours before the print — not capitulation on the rating, but a meaningful acknowledgment that the bar has shifted. UBS made a similar trim in early August, dropping its target from $285 to $245 while holding Buy. The consensus mean target is $242, against a stock now at $141 — a gap wide enough to reflect either deep Street conviction that the selloff is overdone, or targets that haven't fully repriced to where the stock actually is. The bull case centers on cloud revenue running at 41% growth and AI infrastructure demand up 243% year-on-year, with remaining performance obligations reportedly up 325% and FY27 guidance raised toward $90 billion. The bear case points to high expectations that any AI monetization stumble will punish, elevated international exposure, and competitive pressure in the database market. The ORTEX EPS momentum scores sit at 64 over 30 days and 71 over 90 days — above the median, but not exceptional enough to defuse the valuation anxiety.
The earnings history makes the setup concrete. The last two prints produced day-one moves of -10.5% and -3.7%, and five-day moves of -10.8% and -9.8%. Both times the stock fell and kept falling through the week. That is not a prediction — it is simply the pattern the stock has established at recent results. The ORTEX short score of 31.3 has crept up only marginally over the past week, consistent with the prior notes' observation that the caution is options-driven rather than short-seller driven.
Peers offered no shelter on Tuesday. MSFT fell 1.2% on the day, CDNS dropped 7.6%, and DMRC shed 7.2%. The software and AI infrastructure cohort sold off broadly, which partially explains Oracle's session but doesn't account for the magnitude of the move — ORCL's 5.2% loss was steeper than most of its correlated names.
The September 4 print is the only event that matters now. The question is whether the 41% cloud growth figure holds and whether the company can address concerns around AI monetization timelines — with the stock having already given back a meaningful chunk of its month-long rally in a single session before the report even lands.
See the live data behind this article on ORTEX.
Open ORCL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
